Caplin Point Laboratories · NSE: CAPLIPOINT · BSE: 524742
Q2 FY19 results · Jul–Sep 2018
Caplin Point Laboratories reported revenue from operations of ₹155.86 crore and net profit of ₹43.50 crore for Q2 FY19 (Jul–Sep 2018), on a consolidated basis.
| Item | Q2 FY19 | Q2 FY18 | YoY | Q1 FY19 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 155.86 | — | — | — | — |
| Other income | 7.01 | — | — | — | — |
| Total income | 162.88 | — | — | — | — |
| Profit before tax | 57.20 | — | — | — | — |
| Net profit for the period | 43.50 | — | — | — | — |
| Attributable to shareholders of the company | 46.86 | — | — | — | — |
| EPS, basic (₹) | 6.21 | — | — | — | — |
| Net margin (%) | 27.9 | — | — |
| Item | Q2 FY19 | Q2 FY18 | YoY | Q1 FY19 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 131.24 | — | — | 125.16 | +4.9% |
| Other income | 6.67 | — | — | 18.05 | −63.1% |
| Total income | 137.91 | — | — | 143.22 | −3.7% |
| Profit before tax | 43.32 | — | — | 53.14 | −18.5% |
| Net profit for the period | 29.62 | — | — | 41.36 | −28.4% |
| EPS, basic (₹) | 3.95 | — | — | 0.00 | — |
| Net margin (%) | 22.6 | — | 33.0 |
Consolidated
- Filed with BSE
- 08 Nov 2018, 15:51 IST
- Board meeting
- 02 Nov 2018
- Period
- 01 Jul 2018 to 30 Sep 2018
- Review status
- Unaudited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 08 Nov 2018, 15:51 IST
- Board meeting
- 02 Nov 2018
- Period
- 01 Jul 2018 to 30 Sep 2018
- Review status
- Unaudited
- Source
- XBRL filing on BSE